Pharmafile Logo
Pharmafocus logo
Advanced Search
david_cameron

David Cameron pledges seven-day GP service by 2020

October 5, 2015
Medical Communications NHS, david cameron

Millions of patients will benefit from ground-breaking plans for seven-day access to both their GPs and hospitals, British Prime Minister …

News
hilary_clinton

Hillary Clinton takes aim at pharma industry in White House bid

October 5, 2015
Medical Communications, Sales and Marketing turing

Hillary Clinton has taken aim at the pharmaceutical industry with a campaign advert airing in two US states, in which …

News
sermo

New partnership will speed medical diagnoses through crowdsourcing

October 5, 2015
Medical Communications, Sales and Marketing Global Genes, Sermo

The global social network for physicians, SERMO, is partnering with Global Genes, a leading rare disease patient advocacy organisation, to provide …

News

Woodley Equipment to Attend Global Site Solutions Summit, Florida, USA

October 2, 2015
Manufacturing and Production, Research and Development woodley equipment

Woodley Equipment will attend the upcoming Global Site Solutions Summit in Florida, USAThe Global Site Solutions Summit is taking place …

News
Press release
abbvie_theresa_may

Home Secretary Theresa May opens Abbvie’s new UK offices

October 2, 2015
Medical Communications AbbVie

AbbVie today opened new UK offices, in a ceremony presided over by Theresa May, Home Secretary and MP for Maidenhead.The company, …

News
stephen_gough

Professor Stephen Gough joins Novo Nordisk as senior principal clinical scientist

October 2, 2015
Medical Communications, Research and Development Novo Nordisk, Professor Stephen Gough

Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …

Appointment
genzyme_logo

Genzyme opts into Alnylam’s Thrombosis program

October 2, 2015
Medical Communications, Research and Development Alnylam, Genzyme, Sanofi, haemophilia

Sanofi subsidiary Genzyme has elected to opt into Alnylam’s investigational ALN-AT3 hemophilia program for development and potential future commercialisation in …

News
lyrica

Legal analysis: a summary of the Lyrica pregabalin case and the issue of cross-label use in Europe

October 2, 2015
Medical Communications Lyrica, Pfizer

The Warner Lambert v Actavis pregabalin cases have been before the UK Courts on no less than seven occasions since the beginning of …

Feature
generic_doctor

Survey finds GPs have negative views of pharma

October 2, 2015
Medical Communications

A survey by healthcare data and intelligence provider Binley’s has found that more than 40% of GPs have a negative …

News
sandoz_building

FDA accepts Sandoz submission for Amgen biosimilar

October 2, 2015
Medical Communications, Research and Development Amgen, FDA, Novartis, Sandoz, biosimilars

Sandoz, a Novartis company and a global leader in biosimilars, has announced today that the US Food and Drug Administration …

News
gene

Berg joins Genomics England project to sequence 100,000 genomes

October 2, 2015
Medical Communications, Research and Development Berg, Genomics england, artificial intelligence

Boston-based biopharmaceutical company Berg has announced it will join an industry collaboration with Genomics England, with the goal of sequencing …

News
stephen-whitehead-200

CEO Stephen Whitehead leaves ABPI

October 1, 2015
Medical Communications ABPI, Alison Clough, Stephen Whitehead

The ABPI has confirmed that CEO Stephen Whitehead has left the organisation. Speaking on behalf of the Board, John Kearney, …

News
karen_bernstein

Dr Karen Bernstein joins Ovid and Vitae boards

October 1, 2015
Medical Communications, Sales and Marketing Dr Karen Bernstein, Ovid Therapeutics, Vitae Pharmaceuticals

Ovid Therapeutics has announced the appointment of Karen Bernstein to the company’s Board of Directors. Dr Bernstein says: “I have …

Appointment
lungs_shiz

Verona Pharma’s respiratory drug proves positive in study

October 1, 2015
Research and Development COPD, verona pharma

Verona Pharma has announced encouraging positive headline data of the third and final part of a randomised, clinical study in …

News
crp_test

Quick test minimises unnecessary antibiotic prescribing

October 1, 2015
Medical Communications antibiotic resistance

New data presented at this week’s Royal College of General Practitioners (RCGP) Annual Conference reveals that in real-world general practice, …

News
novartissunlight_copy

Novartis’s secukinumab meets Phase 3 goals

October 1, 2015
Research and Development Novartis, Secukinumab, arthritis

Novartis has announced that its secukinumab medication for treatment of psoriatic arthritis (PsA), met its primary endpoint in the pivotal …

News
sayana_press_and_pack

Pfizer’s self-injectable contraceptive becomes UK’s first

September 30, 2015
Medical Communications, Research and Development, Sales and Marketing Pfizer, Syayana Press

Pfizer’s injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the UK for administration by self-injection following …

News
novartis

Study shows Novartis’s Afinitor positively reduces tumors

September 30, 2015
Research and Development Afinitor, Novartis

Novartis has announced the results of a Phase III pivotal study, showing Afinitor (everolimus) tablets reduced the risk of progression …

News

Genentech’s ocrelizumab shows efficacy in phase III trial

September 30, 2015
Research and Development Genentech, MS, Roche, ocrelizumab

Roche subsidiary Genentech has announced positive results from a pivotal phase III study of its investigational medicine ocrelizumab in people …

News
heptares_logo

Heptares awarded $5.5 million grant to combat cocaine addiction

September 30, 2015
Research and Development Heptares

Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company, has been awarded a grant from the National Institute …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026